Ruthenium(II)–Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis-Reference-Cited by-同舟云学术

Ruthenium(II)–Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis

Published:2022-08-01 Issue:15 Volume:65 Page:10567-10587
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Cervinka Jakub¹²,Gobbo Alberto³⁴,Biancalana Lorenzo³^ORCID,Markova Lenka¹^ORCID,Novohradsky Vojtech¹^ORCID,Guelfi Massimo³,Zacchini Stefano⁴^ORCID,Kasparkova Jana¹⁵^ORCID,Brabec Viktor¹^ORCID,Marchetti Fabio³^ORCID

Affiliation:

1. Czech Academy of Sciences, Institute of Biophysics, Kralovopolska 135, CZ-61265 Brno, Czech Republic

2. Faculty of Science, Department of Biochemistry, Masaryk University, Kamenice 5, CZ-62500 Brno, Czech Republic

3. Department of Chemistry and Industrial Chemistry, University of Pisa, Via G. Moruzzi 13, I-56124 Pisa, Italy

4. Department of Industrial Chemistry “Toso Montanari”, University of Bologna, Viale Risorgimento 4, I-40136 Bologna, Italy

5. Faculty of Science, Department of Biophysics, Palacky University in Olomouc, Slechtitelu 27, CZ-78371 Olomouc, Czech Republic

Funder

Grantov? Agentura Cesk? Republiky

Universit? di Pisa

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00722

Reference122 articles.

1. Metallodrugs are unique: opportunities and challenges of discovery and development

2. A survey of the mechanisms of action of anticancer transition metal complexes

3. Classification of Metal-Based Drugs according to Their Mechanisms of Action

4. Cisplatin: The first metal based anticancer drug

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced DNA damage and anti-proliferative activity of a novel ruthenium complex with a chlorambucil-decorated ligand;Journal of Inorganic Biochemistry;2024-11

2. Four new ruthenium(II) coordination compounds bearing coumarin derivatives as anticancer agents;Polyhedron;2024-11

3. Selective Targeting of Regulated Rhabdomyosarcoma Cells by Trinuclear Ruthenium(II)–Arene Complexes;Journal of Medicinal Chemistry;2024-04-03

4. Evaluation of heteroscorpionate ligands as scaffolds for the generation of Ruthenium(II) metallodrugs in breast cancer therapy;Journal of Inorganic Biochemistry;2024-04

5. Single-Crystal X-ray Structure Determination of Tris(pyrazol-1-yl)methane Triphenylphosphine Copper(I) Tetrafluoroborate, Hirshfeld Surface Analysis and DFT Calculations;Crystals;2024-02-03